. Over the past few years, a series of susceptibility genes have been identified to be implicated with breast cancer risk, including high-penetrance genes (BRCA1, BRCA2, TP53 and PTEN), moderate-penetrance genes (CHEK2, ATM, BRIP1 and PALB2) and common low-penetrance variants in multiple genes (3).
However, less than 20% of familial risk of breast cancer can be explained by high-to-moderate penetrance genes whereas ~9% have been attributed to low-penetrance variants (4, 5) . Therefore, there are still important regions harboring genetic variants associated with breast cancer risk to be further identified.
MiRNAs are a class of small (~20-22 nt), non-coding RNAs that exert their regulatory effects by incomplete combination to target sequences mainly on 3'-untranslated regions (UTRs) of messenger RNA (mRNA) (6) . A single miRNA can bind to approximate 200 genes and potentially regulate the expression of nearly 30% of human mRNAs (7) . A number of studies have highlighted the importance of miRNA in the development of cancers. MiRNA expression levels signify initiation, progression, metastasis of human tumors and even the different neoplasm types (8) .
For example, expressions of miR-200 family were found to be lost in invasive breast cancer cell lines with mesenchymal phenotype (9) . Moreover, knockdown of miR-21 increased TIMP3 protein expression and luciferase reporter activity, suggesting miR-21 might promote invasion in breast cancer cells via its regulation of TIMP3 (10) .
Genetic variants may modulate the miRNA-mRNA interaction through altering miRNA expression, maturation, creating or destroying the miRNA binding sites, and result in diverse functional consequences (11, 12) . As yet, genetic variants in pre-miRNA and mature miRNA regions have been implicated in cancer susceptibility, prognosis and sensitivity to chemotherapy (13) (14) (15) (16) 
Materials and methods

Ethics Statement
This study was approved by the institutional review board of Nanjing Medical
University. The design and performance of current study involving human subjects were clearly described in a research protocol. All participants were voluntary and would complete the informed consent in written before taking part in this research.
Study population
University. All subjects were genetically unrelated ethnic Han Chinese women from affinity of miRNA-mRNA were finally included in this study (Table 1 ).
All 24 SNPs were genotyped in stage 1 samples using TaqMan OpenArray Genotyping System (Applied Biosystems Inc.). Promising SNPs were further validated in stage 2 samples using ABI PRISM 7900 HT platform (Applied Biosystems Inc.). The genotyping methods and quality control have been described previously (21) . The overall call rates of 24 SNPs in stage 1 were from 96.2% to 99.2%. About 5% of samples in stage 1 were randomly selected to be repeated on ABI PRISM 7900 HT platform and the concordance rates were 97.9% to 100%.
RAD52 3'-UTR luciferase reporter plasmid
The 3'-UTR region of RAD52 containing the putative recognition site rs7963551 was amplified from a DNA sample carrying AA genotype. The primers were Plasmid containing the rs7963551 C allele was generated using site-specific mutagenesis method. All the constructs used in this study were restriction mapped and sequenced to confirm the authenticity.
Transient transfections and luciferase assays
293T, Hela and MCF-7 cells were maintained in DMEM respectively supplemented with 10% heat-inactivated fetal bovine serum (Gibco) and 50 ug/ml streptomycin (Gibco) at a 37℃ incubator supplemented with 5% CO2. Transfections were performed with cells using Lipofectamine2000 according to manufacturer's 
Statistical analyses
Student t test (for continuous variables) and χ 2 test (for categorical variables) were used to examine the differences in the distributions of demographic characteristics, selected variables, and genotype frequencies of 24 SNPs between cases and controls.
The associations between genotype and breast cancer risk were estimated by calculating odds ratios (ORs) and 95% confidence intervals (CIs) through logistic regression model with adjustment for age, age at menarche and menopausal status.
Differences in the expression levels of RAD52 among subgroups were examined using t-test. All of the statistical analyses were performed with Statistical Analysis System software (9.1.3; SAS Institute, Cary, NC, USA).
Result
The information of 24 SNPs was described in Table 1 . Two SNPs (rs1573613 and rs198978) showed departures from Hardy-Weinberg equilibrium among controls (P<0.05) and were excluded in the further analysis. The association results of 22
SNPs in con-dominant and additive models in stage 1 showed that three SNPs (JARID1B rs10494836, CYP2E1 rs10857748, RAD52 rs7963551) were suggestively 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 As shown in Table 3 , stratification analysis showed that the protective effect of rs7963551 was more prominent in women with early age at first live birth (OR = 0.71, 95% CI = 0.58-0.87, P for heterogeneity = 0.02). Furthermore, a significant interaction between rs7963551 and age at first live birth was detected on the risk of breast cancer (P for interaction = 0.04) ( Table 4 ). Among women with early age at first live birth (<25 years old), those with CC genotype had a 62% reduced risk of breast cancer (OR = 0.38, 95% CI = 0.24-0.59).
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As predicted using RNAhybrid (37), hsa-let-7 has a lower minimum free energy (MFE) with C allele (｜MFE｜=10.4kcal/mol) of rs7963551 in RAD52 than that with A allele (｜MFE｜=11.1kcal/mol). Thus, we hypothesized the C allele might lead to an increased expression of RAD52 resulted from reduced miRNA repression. To test 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 at Nanjing Medical Univeristy on December 5, 2012 http://carcin.oxfordjournals.org/ Downloaded from F o r P e e r R e v i e w 11 RAD52 C2259T (rs11226) and ERCC1 C354T (rs11615) were associated with the ER/PR negative breast cancer cases (42) . Another study detected the loss of heterozygosity (LOH) in the region harboring RAD52 in 16% breast tumors, which might support the importance of RAD52 in the development of breast cancer (43) .
Human let-7 family members were reported to be down-regulated in several cancers acting as a tumor suppressor by regulating multiple oncogenes, such as MYC, H-RAS and HMGA2 (22, (44) (45) (46) . According to in silico analysis using RNAhybrid database, let-7 is predicted to strongly bind with the target site of RAD52 harboring A allele of rs7963551. Luciferase assay indicated that the transcription activity of reporter gene with rs7963551 C allele was significantly increased than that with A allele. The up-regulated level of RAD52 might enhance the DNA repair capacity and result in an inhibition to tumorigenesis. This result was consistent with the association results that the C allele of rs7963551 was associated with a decreased risk of breast cancer. Further functional studies are required to uncover the exact mechanism of this variant.
Reproductive factors including age at first live birth have been established as breast cancer risk-related factors due to different exposure of endogenous hormones (47). First full-term pregnancy can change long-term hormonal levels such as prolactin reduction, estrogen reduction and sex hormone-binding globulin elevation, providing a further protection against breast cancer (48). Moreover, early age at first pregnancy may strengthen the protective effect and induce a refractory state of mammary gland against carcinogenesis in humans (49, 50). During pregnancy, breast epithelial cells rapidly proliferated accompanying a mass of DNA replication response to the estrogen surges. Base mispairing spontaneously emerge in this process more frequently and thus required stronger DNA repair capacity. In our study, a significant interaction was observed between rs7963551 and age at first live birth, suggesting that 22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 at Nanjing Medical Univeristy on December 5, 2012 http://carcin.oxfordjournals.org/ Downloaded from 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
